LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
49 hedge funds and large institutions have $87.6M invested in LYRA THERAPEUTICS INC in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 4 closing their positions.
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
14% more funds holding
Funds holding: 43 → 49 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 13
0.16% less ownership
Funds ownership: 1.33% → 1.17% (-0.16%)
11% less capital invested
Capital invested by funds: $97.9M → $87.6M (-$10.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.16M |
| 2 |
BlackRock
New York
|
+$1.05M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$950K |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$687K |
| 5 |
Two Sigma Investments
New York
|
+$619K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$9.3M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$7.96M |
| 3 |
AAA
Affinity Asset Advisors
New York
|
-$570K |
| 4 |
JP Morgan Chase
New York
|
-$545K |
| 5 |
Millennium Management
New York
|
-$502K |
LYRA Hedge Fund Activity: Q1 2021 in Review
49 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q1 2021, worth a combined $87.6M — down 11% from $97.9M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new LYRA positions and 4 closed out — a net gain of 6 holders — while 13 added to existing stakes and 13 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.16M. The largest seller was RA Capital Management, exiting entirely with an estimated $9.3M sold.
- 49 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q1 2021, up from 43 in Q4 2020.
- Funds reported $87.6M of LYRA THERAPEUTICS INC stock for Q1 2021, down 11% quarter-over-quarter.
- 10 funds opened new LYRA THERAPEUTICS INC positions in Q1 2021 and 4 closed out, a net change of +6 holders.
- The largest LYRA THERAPEUTICS INC buyer in Q1 2021 was Morgan Stanley, an estimated $1.16M added.
- The largest LYRA THERAPEUTICS INC seller in Q1 2021 was RA Capital Management, an estimated $9.3M sold.
Based on aggregated 13F filings for Q1 2021.